| Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer AR Asmaa M. Zahran, Omnia El-Badawy, Wageeh A. Ali, Zainab Gaber Mahran ... Plos One 16 (https://doi. org/10.1371/journal.pone.02), 17, 2021 | 35* | 2021 |
| Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia AM Zahran, MF Mohammed Saleh, MM Sayed, A Rayan, AM Ali, HF Hetta Cancer Biomarkers 22 (3), 587-595, 2018 | 28 | 2018 |
| Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular Carcinoma HFH Asmaa M Zahran, Mona M. Abdel Meguid, Ahmed M. Ashmawy, Amal Rayan, Azza ... THE EGYPTIAN JOURNAL OF IMMUNOLOGY 25, 45-52, 2018 | 22 | 2018 |
| Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience AM Zahran, SM Moeen, AF Thabet, A Rayan, MH Abdel-Rahim, ... Leukemia & Lymphoma 61 (7), 1645-1652, 2020 | 21 | 2020 |
| Survival outcomes of CD34+CD38−LSCs and their expression of CD123 in adult AML patients HFH Asmaa M. Zahran, Sanaa Shaker Aly, Amal Rayan, Omnia El-Badawy, Maged ... Oncotarget 25 (doi: 10.18632/oncotarget.26118), 34056–34065, 2018 | 21* | 2018 |
| Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma HFH Asmaa M Zahran , Zeinab Albadry M Zahran , Omnia El-Badawy , Mona H ... immunologic research 67 (doi: 10.1007/s12026-019-09075-x.), 157-165, 2019 | 19 | 2019 |
| Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia KIEOEB Asmaa M. Zahran, Azza Shibl, Amal Rayan, Mohamed Alaa Eldeen Hassan ... Scientific reports 11 (https://doi.org/10.1038/s41598-021-94469), 2021 | 16 | 2021 |
| Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes AM Zahran, HF Hetta, A Rayan, AS Eldin, EA Hassan, H Fakhry, ... Cancer Immunology, Immunotherapy 69, 1253-1263, 2020 | 13 | 2020 |
| COVID-19 infection in patients with comorbidities: clinical and immunological insight O El-Badawy, NM Elsherbiny, D Abdeltawab, DM Magdy, LM Bakkar, ... Clinical and Applied Thrombosis/Hemostasis 28, 10760296221107889, 2022 | 12 | 2022 |
| Prognostic role of monocytic myeloid-derived suppressor cells in advanced non-small-cell lung cancer: relation to different hematologic indices AM Zahran, HF Hetta, ZAM Zahran, A Rashad, A Rayan, DO Mohamed, ... Journal of immunology research 2021, 2021 | 11 | 2021 |
| Overexpression of PD-1 and CD39 in tumor infiltrating lymphocytes compared with peripheral blood lymphocytes in triple negative breast cancer OEB Asmaa M. Zahran1‡, Amal RayanID2‡*, Zeinab Albadry M. Zahran3 , Wael M ... Plos One, 17, 2022 | 9* | 2022 |
| Pretreatment detection of circulating and tissue CD133+ CD44+ cancer stem cells as a prognostic factor affecting the outcomes in Egyptian patients with colorectal cancer HFH Asmaa M Zahran, Amal Rayan, Hussein Fakhry, Alia M Attia, Ahmed M ... Cancer Management and Research 11 (http://dx.doi.org/10.2147/CMAR.S189653 …, 2019 | 9 | 2019 |
| Reviving up dendritic cells can run cancer immune wheel in non‑small cell lung cancer: a prospective two‑arm study AMZHFHSMESSA Rayan Cancer Immunology, Immunotherapy, 10, 2020 | 8 | 2020 |
| Accumulation of Regulatory T cells in triple negative breast cancer can boost immune disruption MHAR Asmaa M. Zahran1, Omnia El-Badawy2, Lamiaa M. Kamel3, Amal Rayan4 ... Cancer Management and Research 3 (doi: 10.2147/CMAR.S285128.), 6019-6029, 2021 | 6 | 2021 |
| Prognostic Significance of Circulating CD28 Negative Suppressor T cells and Memory B cells in Patients With Breast Cancer AR Asmaa M. Zahran, Asmaa S. Shaltout, Hussein Fakhry, Salah M. Khallaf, Ola ... Iran J Immunol 17 (doi: 10.22034/iji.2020.83420.1625.), 19, 2020 | 6* | 2020 |
| Genetic polymorphisms in XRCC1, OGG1, and XRCC3 DNA repair genes and DNA damage in radiotherapy workers AHMSNNZHMFAAMMAEA Rayan Environmental Science and Pollution Research, 14, 2020 | 6* | 2020 |
| Upregulation of CD146 in pediatric B-cell acute lymphocytic leukemia and its implications on treatment outcomes AM Zahran, O El-Badawy, KI Elsayh, WMY Mohamed, KF Riad, ... Journal of Immunology Research 2020, 2020 | 4 | 2020 |
| Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience DAG Amal Rayana,∗, Samya Abdel-Kareema, Huda Hasana, Asmaa M. Zahranb Reports of Practical Oncology and Radiotherapy 25 (https://doi.org/10.1016/j …, 2020 | 3 | 2020 |
| Efficacy of Docetaxel and Oxaliplatin Regimen as a Second-Line Therapy for Patients with Advanced Pancreatic Adenocarcinoma ARONAFASHAHAM Zahran Journal of Gastrointestinal Cancer, 6, 2018 | 3 | 2018 |
| Role of pretreatment inflammatory indicators in pediatric acute leukemias; where do we stand? A prospective cohort study HMEAR Asmaa M. Zahrana, Khalid F. Riadb, Khalid I. Elsayhc Cancer Biomarkers 29 (DOI 10.3233/CBM-201790), 553–564, 2020 | 2 | 2020 |
